Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Perspective on Multi-target Drugs for Alzheimer’s Disease
Ondřej Benek, Jan Korábečný, Ondřej Soukup
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 7, pp. 434-445
Closed Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports (2021) Vol. 48, Iss. 7, pp. 5629-5645
Open Access | Times Cited: 183
Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
Łucja Justyna Walczak-Nowicka, Mariola Herbet
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9290-9290
Open Access | Times Cited: 161
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
C. Kwon Kim, Yin Rui Lee, Lynnett Ong, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 1, pp. 83-100
Open Access | Times Cited: 124
Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases
Erika Plazas, Mónica C. Avila M, Diego Ricardo Muñoz-Cendales, et al.
Pharmacological Research (2022) Vol. 177, pp. 106126-106126
Closed Access | Times Cited: 89
Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model
Luodan Yang, Chongyun Wu, Emily Parker, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 2205-2231
Open Access | Times Cited: 72
Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Rishika Dhapola, Samir Kumar Beura, Prajjwal Sharma, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 64
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
Shuai Wen, Guan Wang, Yiwen Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7963-7990
Closed Access | Times Cited: 101
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 84
Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations
Rafael Fernades Costa, Larissa Córdova Turones, Keilah Valéria Naves Cavalcante, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 82
Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine
Yumeng Lin, You Zhang, Dongyang Wang, et al.
Phytomedicine (2022) Vol. 107, pp. 154481-154481
Closed Access | Times Cited: 55
Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
Chongyun Wu, Luoman Yang, Shu Feng, et al.
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 46
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 46
Direct sunlight and partial shading alter the quality, quantity, biochemical activities of Kaempferia parviflora Wall., ex Baker rhizome essential oil: A high industrially important species
Twahira Begum, Roktim Gogoi, Neelav Sarma, et al.
Industrial Crops and Products (2022) Vol. 180, pp. 114765-114765
Closed Access | Times Cited: 40
Polypharmacology: promises and new drugs in 2022
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 755-770
Open Access | Times Cited: 27
Pareto optimization to accelerate multi-objective virtual screening
Jenna C. Fromer, David Graff, Connor W. Coley
Digital Discovery (2024) Vol. 3, Iss. 3, pp. 467-481
Open Access | Times Cited: 15
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Ageing Research Reviews (2024) Vol. 97, pp. 102309-102309
Closed Access | Times Cited: 14
Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 14
Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease
Aliki Drakontaeidi, Eleni Pontiki
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 582-582
Open Access | Times Cited: 10
Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition
Anna Misiachna, Barbora Svobodová, Jakub Netolický, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116130-116130
Open Access | Times Cited: 8
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access | Times Cited: 1
Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors
Sandeep Bindra, Ehab M. Mostafa, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Mitochondrial Dysfunction in Neurodegenerative Diseases
Han‐Mo Yang
Cells (2025) Vol. 14, Iss. 4, pp. 276-276
Open Access | Times Cited: 1
Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration
Maja Jazvinšćak Jembrek, Nada Oršolić, Lucija Mandić, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1628-1628
Open Access | Times Cited: 51
High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer’s Disease through Multitarget Approach
Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 937-937
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top